Page 9 - Key Challenges News Today

While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.

Middle East & Africa witnessed a 17.1% drops in IT hiring activity in the pharma industry in December 2021, according to GlobalData’s Job Analytics index

The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this... | February 4, 2022

NorthSea Therapeutics has commenced a Phase I trial of SEFA-6179 in adult subjects, to obtain a preliminary orphan indication to treat IFALD.

The US FDA cleared IND application of Viridian Therapeutics to commence Phase I trial of its antibody VRDN-002 to treat thyroid eye disease.

Daiichi Sankyo has commenced a Phase I/II/III clinical trial of a booster dose of Covid-19 vaccine, DS-5670, in Japan.

Despite the publicity, all sort of advocacy and lobbying by various interested parties involved, the so-called single wholesale network (SWN) model proposition by Digital National Berhad (DNB), as it stands today, doesn’t hold water from the perspectives of nation-building, technical feasibility, financial and commercial viability as well as governance and integrity

Eisai has enrolled the first subject in Phase II/III Tau NexGen trial of E2814 for dominantly inherited Alzheimer’s disease (DIAD).

Clinical Trial Arena lists five of the most popular tweets on neurology in Q3 2021 based on GlobalData’s Pharmaceuticals Influencer Platform.

Respiration is an irreplaceable human life process, starting at the time of birth and continuing until death. For many decades, a healthy human body has been able to breathe, but due to rising levels of pollution in metropolitan cities and lifestyles involving cigarette smoking, clogging of airways and other lung st...